31 Oct 2025 EPA issues proposed registration decision for Biotalys’ EVOCA™ biofungicide Multiple categories
21 Oct 2025 KU Leuven study uncovers how breast cancer cells pause to survive chemotherapy — and how to target them Multiple categories
20 Oct 2025 Belgian neurotech startup Farow raises €1.6M to expand its AI platform for epilepsy and Parkinson’s disease Multiple categories
16 Oct 2025 ACTIV by APHEA bio® proves its value in Poland: stronger yields in successful 2024–25 season Multiple categories
08 Oct 2025 Confo Therapeutics awarded VLAIO grant for development of ultra-long-acting antibody-based GPCR therapeutics in endocrine and metabolic conditions Multiple categories
06 Oct 2025 Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025 Multiple categories
03 Oct 2025 New approach can drastically reduce antibiotic prescription for children Multiple categories
24 Sep 2025 Enhertu plus pertuzumab granted Priority Review in the US as 1st-line treatment for patients with HER2-positive metastatic breast cancer Multiple categories
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
